Effects of azathioprine and its metabolites on repair mechanisms of the intestinal epithelium in vitro

Regulatory Peptides

Volumn 131, Issue 1-3, 2005, Pages 1-11

  Schroll, Sebastian ^a   Sarlette, Alexander ^a   Ahrens, Katja ^a   Manns, Michael P ^a   Göke, Michael ^a,b,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Apoptosis; Azathioprine; Immunosuppression; Inflammatory bowel diseases; Intestinal epithelium; Proliferation; Restitution

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; AZATHIOPRINE; DNA; HISTONE; LIPOCORTIN 5; MERCAPTOPURINE; PROPIDIUM IODIDE; PURINE ANTAGONIST; THYMIDINE; TIOGUANINE; TRITIUM;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; INTESTINE EPITHELIUM; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING; TISSUE REPAIR;

ANIMALS; APOPTOSIS; AZATHIOPRINE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; RATS;

EID: 25844472389     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2005.03.001     Document Type: Article

References (56)

1. J. Medina, L. Garcia-Buey, and R. Moreno-Otero Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis Aliment Pharmacol Ther 17 2003 1 16
2. S.E. Gabriel, D. Coyle, and L.W. Moreland A clinical and economic review of disease-modifying antirheumatic drugs PharmacoEconomics 19 2001 715 728
3. D.S. Pisetsky, and E.W. St Clair Progress in the treatment of rheumatoid arthritis JAMA 286 2001 2787 2790
4. D.G. Kuiper-Geertsma, and R.H. Derksen Newer drugs for the treatment of lupus nephritis Drugs 63 2003 167 180
5. V. Sinovich, and J. Snow Protracted superficial Wegener's granulomatosis Australas J Dermatol 44 2003 207 214
6. B.C. Kieseier, and H.P. Hartung Current disease-modifying therapies in multiple sclerosis Semin Neurol 23 2003 133 146
7. M.P. Pender, and N.P. Wolfe Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects Intern Med J 32 2002 554 563
8. J. Newsom-Davis Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome Semin Neurol 23 2003 191 198
9. A. Moudgil Renal transplantation Indian J Pediatr 70 2003 257 264
10. M. Presta, M. Belleri, A. Vacca, and D. Ribatti Anti-angiogenic activity of the purine analog 6-thioguanine Leukemia 16 2002 1490 1499
11. R.A. De Abreu, R.C. Trueworthy, A.B. van Kuilenburg, T.M. Vogels-Mentink, L.H. Lambooy, and A.H. van Gennip Combination therapy in childhood leukaemia: in vitro studies of thiopurines and inhibitors of purine metabolism on apoptosis Ann Clin Biochem 40 2003 70 74
12. D.K. Podolsky Inflammatory bowel disease N Engl J Med 347 2002 417 429
13. P. Rutgeerts A critical assessment of new therapies in inflammatory bowel disease J Gastroenterol Hepatol 17 2002 S176 S185 [Suppl]
14. U. Mahadevan, and W.J. Sandborn Evolving medical therapies for Crohn's disease Curr Gastroenterol Rep 3 2001 471 476
15. L.J. Derijks, D.J. de Jong, L.P. Gilissen, L.G. Engels, P.M. Hooymans, and J.B. Jansen 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment Eur J Gastroenterol Hepatol 15 2003 63 67
16. M.C. Dubinsky, P.V. Hassard, E.G. Seidman, L.Y. Kam, M.T. Abreu, and S.R. Targan An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy Inflamm Bowel Dis 7 2001 181 189
17. M.C. Dubinsky, E.J. Feldman, M.T. Abreu, S.R. Targan, and E.A. Vasiliauskas Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine Am J Gastroenterol 98 2003 1058 1063
18. M.C. Dubinsky, E.A. Vasiliauskas, H. Singh, M.T. Abreu, K.A. Papadakis, and T. Tran 6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients Gastroenterology 125 2003 298 303
19. S.J. Rulyak, M.D. Saunders, and S.D. Lee Hepatotoxicity associated with 6-thioguanine therapy for Crohn's disease J Clin Gastroenterol 36 2003 234 237
20. M. Göke, and D.K. Podolsky Remission, relapse, intestinal healing and repair S.R. Targan F. Shanahan L.C. Karp S.R. Targan F. Shanahan L.C. Karp Inflammatory bowel disease: from bench to bedside 2003 Kluwer Academic Publishers Boston 197 209
21. M. Göke, and D.K. Podolsky Regulation of the mucosal epithelial barrier Bailliere's Clin Gastroenterol 10 1996 393 405
22. A.J. Wilson, and P.R. Gibson Epithelial migration in the colon: filling in the gaps Clin Sci (Colch) 93 1997 97 108
23. W. Silen Gastric mucosal defense and repair L.R. Johnson L.R. Johnson Physiology of the gastrointestinal tract 1987 Raven Press New York 1055 1069
24. M.W. Babyatsky, G. Rossiter, and D.K. Podolsky Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease Gastroenterology 110 1996 975 984
25. G. D'Haens, K. Geboes, and P. Rutgeerts Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine Gastrointest Endosc 50 1999 667 671
26. W. Miehsler, A. Puspok, T. Oberhuber, and H. Vogelsang Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract Inflamm Bowel Dis 7 2001 99 105
27. G.L. Chan, G.R. Erdmann, S.A. Gruber, A.J. Matas, and D.M. Canafax Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients J Clin Pharmacol 30 1990 358 363
28. G.B. Elion The George Hitchings and Gertrude Elion Lecture. The pharmacology of azathioprine. Significance of azathioprine metabolites Ann N Y Acad Sci 685 1993 400 407
29. E.M. Gonzalez, K. Krejczy, and R.A. Malt Modification of nucleic acid synthesis in regenerating liver by azathioprine Surgery 68 1970 254 258 [discussion 258-9]
30. + T lymphocytes J Clin Invest 111 2003 1133 1145
31. C. Ciacci, S.E. Lind, and D.K. Podolsky Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers Gastroenterology 105 1993 93 101
32. M. Göke, M. Kanai, K. Lynch-Devaney, and D.K. Podolsky Rapid mitogen-activated protein kinase activation by transforming growth factor alpha in wounded rat intestinal epithelial cells Gastroenterology 114 1998 697 705
33. M. Göke, M. Kanai, and D.K. Podolsky Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor Am J Physiol 274 1998 G809 G818
34. M.N. Göke, M. Schneider, W. Beil, and M.P. Manns Differential glucocorticoid effects on repair mechanisms and NF-kappaB activity in the intestinal epithelium Regul Pept 105 2002 203 214
35. M. Göke, A. Zuk, and D.K. Podolsky Regulation and function of extracellular matrix in intestinal epithelial restitution in vitro Am J Physiol 271 1996 G729 G740
36. I.M. Rosenberg, M. Göke, M. Kanai, H.C. Reinecker, and D.K. Podolsky Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function Am J Physiol 273 1997 G824 G832
37. M.M. Weiser Intestinal epithelial cell surface membrane glycoprotein synthesis: I. An indicator of cellular differentiation J Biol Chem 248 1973 2536 2541
38. V. Milovic, I.C. Teller, D. Faust, W.F. Caspary, and J. Stein Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation Eur J Clin Invest 32 2002 29 34
39. K. Schlottmann, F.P. Wachs, R.C. Krieg, F. Kullmann, J. Schölmerich, and G. Rogler Characterization of bile salt-induced apoptosis in colon cancer cell lines Cancer Res 60 2000 4270 4276
40. I. Vermes, C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V J Immunol Methods 184 1995 39 51
41. I. Nicoletti, G. Migliorati, M.C. Pagliacci, F. Grignani, and C. Riccardi A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry J Immunol Methods 139 1991 271 279
42. R. Fonti, G. Latella, G. Bises, F. Magliocca, F. Nobili, and R. Caprilli Human colonocytes in primary culture: a model to study epithelial growth, metabolism and differentiation Int J Colorectal Dis 9 1994 13 22
43. G. Rogler, R. Daig, E. Aschenbrenner, D. Vogl, K. Schlottmann, and W. Falk Establishment of long-term primary cultures of human small and large intestinal epithelial cells Lab Invest 78 1998 889 890
44. C.A. Halfpenny, and N.J. Scolding Immune-modifying agents do not impair the survival, migration or proliferation of oligodendrocyte progenitors (CG-4) in vitro J Neuroimmunol 139 2003 9 16
45. A.I. Fyfe, A. Rosenthal, and A.I. Gotlieb Immunosuppressive agents and endothelial repair. Prednisolone delays migration and cytoskeletal rearrangement in wounded porcine aortic monolayers Arterioscler Thromb Vasc Biol 15 1995 1166 1171
46. A. el-Yazigi, and F.A. Wahab Pharmacokinetics of azathioprine after repeated oral and single intravenous administration J Clin Pharmacol 33 1993 522 526
47. J. Liliemark, B. Pettersson, P. Lafolie, T. Zweig, and C. Peterson Determination of plasma azathioprine and 6-mercaptopurine in patients with rheumatoid arthritis treated with oral azathioprine Ther Drug Monit 12 1990 339 343
48. U. Bär, H. Becker, B. May, D. Mayer, S. Ohlendorf, and P. Otto Über die Pharmakokinetik des Azathioprins im Tierversuch und bei Patienten mit chronischen Lebererkrankungen Verh Dtsch Ges Inn Med 79 1973 943 946
49. D. Malamud, E.M. Gonzalez, H. Chiu, and R.A. Malt Inhibition of cell proliferation by azathioprine Cancer Res 32 1972 1226 1229
50. R. van Furth, A.E. Gassmann, and M.M. Diesselhoff-Den Dulk The effect of azathioprine (Imuran) on the cell cycle of promonocytes and the production of monocytes in the bone marrow J Exp Med 141 1975 531 546
51. S.N. Wickramasinghe Effect of azathioprine on the cell cycle of haemopoietic cells Scand J Haematol 16 1976 38 40
52. T. Yan, S.E. Berry, A.B. Desai, and T.J. Kinsella DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells Clin Cancer Res 9 2003 2327 2334
53. A.H. Chalmers, P.R. Knight, and M.R. Atkinson 6-Thiopurines as substrates and inhibitors of purine oxidases: a pathway for conversion of azathioprine into 6-thiouric acid without release of 6-mercaptopurine Aust J Exp Biol Med Sci 47 1969 263 273
54. P.C. Schofield, I.G. Robertson, and J.W. Paxton Inter-species variation in the metabolism and inhibition of N-[(2′-dimethylamino)ethyl]acridine-4- carboxamide (DACA) by aldehyde oxidase Biochem Pharmacol 59 2000 161 165
55. J.F. Bach Immunosuppression by chemical agents Transplant Proc 3 1971 27 33
56. S. Hortelano, and L. Bosca 6-Mercaptopurine decreases the Bcl-2/Bax ratio and induces apoptosis in activated splenic B lymphocytes Mol Pharmacol 51 1997 414 421